[1] GREGG L P,HEDAYATI S S.Pharmacologic and psychological interventions for depression treatment in patients with kidney disease[J].Curr Opin Nephrol Hypertens, 2020,29(5):457-464.
[2] REYES M,FUERTES J N,MOORE M T,et al.Psychological and relational factors in ESRD hemodialysis treatment in an underserved community[J].Patient Educ Couns, 2020,S0738-3991(20):30320-30327.
[3] DAVEY C H,WEBEL A R,SEHGAL A R,et al.Genetic correlates of fatigue in individuals with end stage renal disease[J].West J Nurs Res,2020,42(12):1042-1049.
[4] TSURUYA K,YOSHIDA H,HARUYAMA N,et al.Clinical significance of fronto-temporal gray matter atrophy in executive dysfunction in patients with chronic kidney disease:the VCOHP study[J].PLoS One,2015,10(12):e0143706.
[5] MARIO B,LUCIA D V,VITTORIO S,et al.New treatment approaches for the Anemia of CKD[J].Am J Kidney Dis,2016,67(1):133-142.
[6] ARVANITIS C D,FERRARO G B,JAIN R K,et al.The blood-brain barrier and blood-tumour barrier in brain tumours and metastases[J].Nat Rev Cancer,2020,20(1):26-41.
[7] MIRANDA A S,CORDEIRO T M,DOS SANTOS LACERDA SOARES T M, et al.Kidney-brain axis inflammatory cross-talk:from bench to bedside[J].Clin Sci 2017,131(11):1093-1105.
[8] LOUVEAU A,SMIRNOV I,KEYES T J,et al.Structural and functional features of central nervous system lymphatic vessels[J].Nature,2015,523(7560):337-341.
[9] 苏文君,曹志永,蒋春雷.抑郁症的炎症机制及诊疗新策略[J].生理报,2017,69(5):715-722.
[10] ZADKAŁ,DZIĘ GIEL P,KULUS M,et al.Clinical phenotype of depression affects interleukin-6 synthesis[J].J Interferon Cytokine Res,2017,37(6):231-245.
[11] SCHMIDT F M,KOCH J,NOWAK C,et al. Ligands and receptors of the TNF superfamily are decreased in major depression and during early antidepressant therapy[J].Journal of Psychiatric Research,2019,119:116-121.
[12] MONDELLI V,CATTANEO A,MURRI M B,et al.Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis:a pathway to smaller hippocampal volume[J].J Clin Psychiatry,2011,72(12):1677-1684.
[13] MAZUMDER M K,GIRI A,KUMAR S,et al.A highly reproducible mice model of chronic kidney disease:evidences of behavioural abnormalities and blood-brain barrier disruption[J].Life Sci,2016,161:27-36.
[14] KIM H J,VAZIRI N D.Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure[J].Am J Physiol Renal Physiol,2010,298(3):F662-671.
[15] D'APOLITO M,DU X,ZONG H,et al.Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure[J].J Clin Invest,2010,120(1):203-213.
[16] OBERG B P,MCMENAMIN E,LUCAS F L,et al.Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease[J]. Kidney Int,2004,65(3):1009-1016.
[17] SZERLIP H M,EDWARDS M L,WILLIAMS B J,et al.Association between cognitive impairment and chronic kidney disease in mexican americans[J].J Am Geriatr Soc,2015,63(10):2023-2028.
[18] ZHAO H R,JIANG T,TIAN Y Y,et al.Angiotensin Ⅱ triggers apoptosis via enhancement of NADPH oxidase-dependent oxidative stress in a dopaminergic neuronal cell line[J].Neurochem Res,2015,40(4):854-863.
[19] JIANG T,ZHANG Y D,ZHOU J S,et al.Angiotensin-(1-7) is reduced and inversely correlates with tau hyperphosphorylation in animal models of Alzheimer's disease[J].Molecular Neurobiology,2016,53:2489-2497.
[20] NAOKI H,KIICHIRO F,MAYUMI Y,et al.Improvement in spatial memory dysfunction by telmisartan through reduction of brain angiotensin II and oxidative stress in experimental uremic mice[J].Life Sci,2014,113(1-2):55-59. |